Alberto Rios
Story Poster
7 Days 'til Aggie Baseball: Montgomery enters talent-rich environment
10 mo ago by Richard Zane
Two-way phenom Braden Montgomery was part of two wildly successful Stanford teams before transferring to A&M this summer. As he prepares for what could be a one-and-done campaign as an Aggie, Montgomery believes he's surrounded by more talent than ever before.
Story Poster
13:40
D1Baseball's Kendall Rogers grades Texas A&M's 2023 campaign
1 yr ago by Nick Savage
Texas A&M's postseason may be done, but there are still 16 teams vying for a spot in Omaha. On Wednesday, D1Baseball's Kendall Rogers joined TexAgs Radio to recap the Ags' showing in Stanford and preview the super regional round this weekend.
Story Poster
21:19
Dramatics & Ecstatics: Haas' heroics boosts A&M into regional final
1 yr ago by Richard Zane
When the Aggies needed a spark most, Hunter Haas answered the call with two game-changing doubles to lift Texas A&M past Stanford, 8-5. Erasing another early deficit, Haas paved the way offensively while Troy Wansing held firm in the ninth for his second save.
Get access to all Premium content today
Start your subscription for just $1
Try Premium Now
Story Poster
35:37
Regional Preview: Impact players, paths to victory in Stanford
1 yr ago by David Sandhop
Texas A&M, Cal State Fullerton and San Jose State join Stanford for the 2023 Stanford Regional at Sunken Diamond this weekend to begin the 2023 NCAA Tournament. Ahead of Friday's opener, David Sandhop takes an in-depth look at each team in the Stanford Regional.
Story Poster
11:01
Peterson: A&M will face true old-school, west coast offense vs. CS Fullerton
1 yr ago by David Nuño
Former Stanford All-American and ESPN baseball analyst Kyle Peterson joined TexAgs Radio to preview the field in Palo Alto this coming weekend. Peterson elaborated on what Texas A&M can expect with Cal State Fullerton's style of play as well as his alma maters.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.